Is the myonuclear domain size fixed? by Van der Meer, SFT et al.
286
Introduction
Skeletal muscle has a remarkable ability to respond to al-
tered functional demands. During disuse, for instance, the mus-
cle atrophies, while in response to overload the muscle
hypertrophies. Whatever the condition that causes muscle fibre
atrophy or hypertrophy, the speed and magnitude of this
change in size are the result of an altered balance between pro-
tein synthesis and degradation. Although protein synthesis and
degradation are regulated by different sets of complex inde-
pendent pathways, there are indications of some interaction
between the two, where specific proteins that stimulate protein
synthesis also inhibit the expression of proteins that increase
the activity of protein degradation pathways1,2. Protein degra-
dation is executed by the interaction of several different pro-
teolytic pathways: 1) the cytosolic calcium-dependent calpain
system, 2) the lysosomal proteases, 3) the ATP-dependent
ubiquitin proteasome system2-4 and 4) caspases5. The rate of
protein synthesis can be regulated by: 1) the rate of protein
translation, 2) the amount of available mRNA and 3) the tran-
scriptional capacity.
The translational capacity is determined by the number and
translational efficiency of ribosomes6. Given that the fraction
of ribosomal RNA accounts for approximately 80-85% of the
total cellular RNA pool7, changes in the total RNA concentra-
tion are generally regarded to reflect a change in the transla-
tional capacity6. The transcriptional capacity is determined, at
least partly, by the amount of available nuclear DNA. While
most cell types (e.g. neuronal cells, macrophages, fibroblasts,
lymphocytes, osteocytes) in mammals are mono-nucleated,
muscle fibres contain multiple nuclei (Figure 1). Single soleus
muscle fibres from 5-month-old rats, for instance, contain ap-
proximately 300 myonuclei per mm muscle fibre length8.
Those nuclei originate from the fusion of multiple myoblasts
into one myotube9 during embryonic development. Muscle nu-
clei, further indicated as myonuclei, have a flattened and elon-
gated shape and their length varies between 11-25 μm
e.g.10,11-15 and does not vary significantly with age and dener-
vation-induced atrophy (Figure 2)14.
For more than a century scientists have had the idea that
each nucleus has a ‘Wirkungskreis’ or ‘volume of influence’16.
The general believe was that nuclear size was related to cyto-
plasmic volume. In other words, it was thought that the size
of mononuclear cells was largely determined by the size of the
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myonucleus17. Only in the 1960s scientists became interested
in the relationship between cell size and number of nuclei in
skeletal muscle18-20. It was, however, Cheek and colleagues
who in 1971 hypothesised that ‘each nucleus held jurisdiction
over a finite volume of cytoplasm’ and developed the concept
of a ‘DNA unit’20. A functional DNA unit was defined as the
content of non-collagen-protein per DNA content. It should be
noted, however, that by measuring the DNA content in a mus-
cle homogenate also nuclei originating from other cell types
(satellite cells, fibroblasts, endothelial cells etc.) are included.
A more accurate assessment of the relationship between num-
ber of nuclei and the muscle fibre size would be based on a
count of the myonuclei in a muscle fibre.
Landing and colleagues, using single muscle fibres, showed
for the first time that the distribution of the nuclei in muscle
fibres follows regular patterns; each nucleus was surrounded
by six other nuclei in an “elongated hexagon” further support-
ing the idea that each myonucleus has a “surface territory” as
indicated by the “cytoplasmic-volume-to-nucleus ratio”21.
Edgerton and Roy22 pointed out that a myonucleus can theo-
retically act in two scenarios as illustrated in Figure 3. Accord-
ing to the model represented in Figure 3A and described by
Cheek20 and Hall and Ralston23 a myonucleus provides all tran-
scripts for a given volume of cytoplasm in its direct surround-
ing. In the model of Figure 3B each myonucleus expresses
only specific proteins, but does so for the whole muscle fibre.
Many observations support the first concept. Some proteins
are not homogeneously expressed over the full length of the
muscle fibre24. In addition, considering the limited half-life of
mRNA and relatively large dimensions of a muscle fibre (they
can be several cm long and up to 0.2 mm in diameter), it seems
unlikely that muscle fibres could maintain their size if tran-
scripts must diffuse over long distances within the fibre22. In-
deed mRNA does not range far from its nucleus of origin25,26.
Besides, the concept of a myonuclear domain can only be use-
ful when one assumes that each myonucleus has a certain spa-
tial limitation to control its surrounding cytoplasm22.
Further support for the concept that each myonucleus has
a limited cytoplasmic volume which it can supply is the ob-
servation that under normal physiological conditions the num-
ber of myonuclei per muscle fibre is proportionally positively
related to muscle fibre size in both animal15,27-29 and human
muscle30,31. If this concept of a constant myonuclear domain
size is true, then any change in the size of a fibre will be ac-
companied by a proportional change in the number of myonu-
clei in that fibre: the possible scenarios are illustrated in
Figure 4B-E. 
In this review we will explore the validity of this concept
by looking at reported changes in myonuclear domain size dur-
ing maturational growth, hypertrophy, atrophy and ageing.
The myonuclear domain in fibres of different type
The myonuclear domain size appears to differ between fibre
types, where it increases from type I to IIA to type IIB/X fi-
bres14,29. In rat gastrocnemius muscle the larger myonuclear
domain size in the type IIA than type I fibres was due to a
lower number of myonuclei, and not a larger size of the IIA
fibres. In contrast, in type IIB/X fibres the number of myonu-
clei in the fibre was similar to that of type I fibres but type
Figure 1. Fragment of a single human vastus lateralis muscle fibre
showing in blue the myonuclei.
Figure 2. Myonuclear length determined in single isolated fibres from
young-adult control (Y-C), young-adult 4-week denervated (Y-DNV),
old control (O-C) and old 4-week denervated (O-DNV) rat gastroc-
nemius muscles (3 fibres from 3-4 muscles in each group). Myonu-
clear length (in μm) was estimated as the longest length of a best-fit
ellipse. The angle of each myonucleus was corrected for the angle at
which the muscle fibre fragment was captured. In three different re-
gions of the fibre the mean sarcomere length was determined to cor-
rect nuclear length for sarcomere length (hence the y-axis presents
myonuclear length normalized for sarcomere length which was in all
cases close to 2.4 μm) and orientation of the nucleus within the fibre.
Each data point represents the mean of 21±3.4 (mean±SEM) myonu-
clei. Using a two-way ANOVA, it appeared that age and denervation
did not have a significant effect on myonuclear length (unpublished
observations).
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IIB/X fibres had a larger fibre cross-sectional area (FCSA)14.
These differences in myonuclear domain size between fibre
types could well be related to the higher oxidative capacity of
the type I and IIA than the type IIB/X fibres since the myonu-
clear domain size is inversely related to the oxidative capacity
of the fibre15,32. Further support for the notion that the myonu-
clear domain size is related to the oxidative capacity of muscle
fibres rather than the myosin heavy chain type of the fibre is
Figure 3. Two concepts of myonuclear domain. The arrows indicate the domain of cytoplasm that the myonuclei supply with mRNA transcripts.
In the left diagram (A) the myonucleus provides the cytoplasm in its direct surrounding of transcripts, whereas in the right diagram (B) it is as-
sumed that each nucleus produces only specific transcripts which diffuse through the whole muscle fibre.
Figure 4. Possible scenarios of changes in myonuclear domain size with different types of muscular adaptation.
S.F.T. Van der Meer et al.: Is the myonuclear domain size fixed?
289
provided by the observation that the type II fibres in the su-
perficial glycolytic region of the rat plantaris muscle with a
relatively low oxidative capacity had a larger myonuclear do-
main than type II fibres in the deep oxidative region of the
plantaris muscle with a high oxidative capacity33. A possible
explanation for the differences in myonuclear domain size be-
tween fibres of different types may be that oxidative fibres
have a faster protein turnover and hence a higher demand for
mRNA transcription, also of mitochondrial proteins. It has in-
deed been observed that protein turnover rate is higher in slow
than in fast muscles2,34. Overall, it signifies that the myonuclear
domain size is not fixed but does vary between fibre types and
with the oxidative capacity of the fibre.
Myonuclear domain and increases in muscle size
Skeletal muscle growth is largely, if not solely, attributable
to an increase in fibre size. According to the concept of the
myonuclear domain this should be associated with a propor-
tional increase in the number of myonuclei to maintain the my-
onuclear domain size. Below we will discuss what happens
during maturational growth of the muscle and exercise- or
overload-induced muscle growth or hypertrophy.
An increase in the number of myonuclei is realised by the
fusion of satellite cells with the existing muscle fibre(s). Satel-
lite cells were discovered by Mauro35 who named them after
their location between the plasma membrane of the muscle
fibre and the basement membrane (also referred to as ‘basal
lamina’) that surrounds the muscle fibre. Once activated the
expression of the myogenic regulatory factor MyoD is in-
creased and the cell starts to divide. During this proliferation
phase the expression of the myogenic regulatory factors will
shift from MyoD to myogenin, which is thought to be crucial
for satellite cell differentiation. At fusion with the muscle fibre,
the satellite-cell nucleus is donated to the existing muscle fibre
and will function as a myonucleus. It should be noted, how-
ever, that not all activated satellite cells differentiate into a my-
onucleus. After proliferation some satellite cells are withdrawn
from the differentiation process36. It is hypothesised that those
satellite cells fall back to a quiescent state and maintain a pool
of satellite cells that can be activated during later repair, re-
generation or hypertrophy36.
Maturational muscle growth
During maturational growth, the lengthening of the bones
is tightly associated with increases in skeletal muscle volume.
An expansion of muscle volume can be achieved by increases
in the number, length and/or cross-sectional area (FCSA) of
the muscle fibres. Since it is generally believed that the number
of muscle fibres is set at around the first months after birth37,38,
the increase in muscle volume during growth must be the result
of an up to 23-fold increase in fibre size39-41 and an increase in
muscle fibre length42,43.
In 1964 Enesco and Puddy reported that the number of my-
onuclei increased during the first three months of growth in
rats, but did not formulate any hypotheses on the relevance of
a possible coupling between the cell size and the number of
nuclei44. In the pectoralis and gastrocnemius muscles from
growing chickens a logarithmic relationship was observed be-
tween the number of nuclei, estimated by the DNA content,
and the muscle fibre diameter18,19. They relied thereby on ear-
lier findings that the DNA-per-nucleus ratio in various mam-
malian cells was a constant value of about 6.2 pg per nucleus20.
In the early reports of nuclear increases during muscle
growth18,44 myonuclei were not discriminated from other nu-
clei. Although Enesco and Puddy demonstrated that the frac-
tion of muscle nuclei, nuclei that were considered inside a
muscle fibre, remained fairly stable (60-70%) in each of four
different rat muscles during their development from 16 to 89
days, those reports should be interpreted with some caution. 
Nevertheless, these early studies were subsequently con-
firmed by additional observations of a substantial increase in
the number of myonuclei per muscle fibre during the early
weeks and months of growth in rodents8,42,45,46. However, the
increase in myonuclear number was shown to be less than the
increase in FCSA and consequently the myonuclear domain
size expands during growth. The expansion of the myonuclear
domain size during maturational growth in rat diaphragm mus-
cle fibres was more pronounced in type IIX than in IIA or type
I muscle fibres46. This suggests that, at least in rat, the growth
of type IIX fibres requires a smaller transcriptional capacity
than is the case for the type I and IIA muscle fibres and corre-
sponds with a lower protein turnover rate in fast than slow fi-
bres2,34, requiring a lower transcriptional activity.
Little is known about changes in myonuclear number during
growth in human muscle, but the few data available suggest
that the pattern observed in rodents and chicken also applies to
human muscle. Muscles of children in the age of 1-2.5 years
old contained approximately half the number of myonuclei per
muscle fibre of those from adult muscles (12-30 years old)41.
At first glance the proportional increase in myonuclei and my-
ofibre diameter suggests that the nuclear domain size remains
constant. However, FCSA increases quadratically with diameter
and hence it is clear that also in this case there is an increase in
the myonuclear domain size during growth. It is unclear, how-
ever, what happens in the first few months after birth. As the
number of satellite cells declined rapidly during the first weeks
of growth of rat skeletal muscles12,42,47,48, it is no surprise that
myonuclear accretion slows down during maturation42.
Overall the changes in FCSA and nuclear number during
growth resemble the situation depicted in Figure 4C where the
nuclear domain size is not constant but rather increases during
maturational muscle growth. It thus seems that the concept of a
constant nuclear domain size needs to be abandoned at least dur-
ing maturational muscle growth. Maturational growth is a spe-
cial situation where the whole body, including the muscle, is
geared to subsequent growth. This requires an exceptional tran-
scriptional activity which is undoubtedly much higher than one
would see in the adult myofibre that finds itself in a more or less
steady state. It is interesting to note, however, that the increase
in myonuclear domain size as a consequence of a larger increase
in FCSA than nuclear number much resembles the larger in-
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crease in FCSA than capillary number during growth, resulting
in an increased capillary supply or ‘capillary domain’ area39.
Also in that case, like the number of myonuclei41, the capillary
number per fibre radius remained constant39 suggesting that the
average distance between myonuclei remains relatively constant
during growth. The significance of this distribution of myonuclei
is something for further exploration.
Hypertrophy
It is a point of discussion whether or not the acquisition of
new myonuclei is required for skeletal muscle hypertrophy49,50.
Table 1 gives an overview of the changes in myonuclear do-
main size during hypertrophy. At a first glance, the increase in
the myonuclear number during hypertrophy in animals29,33,51-53
and young-adult men54 appears to support the notion of a con-
stant myonuclear domain size. The importance of myonuclear
addition for muscle fibre hypertrophy is further supported by
the attenuated55,56 or even prevented hypertrophy after ‘gamma-
irradiation’51,57,58, which destroys the potential of mitotic divi-
sion in various cell types, including the satellite cells. However,
it has been shown that hypertrophy to some extent is possible
without any change in the number of myonuclei33,54,59,60. Using
a cluster-analysis of a 4-months resistance training program in
humans, it was observed that participants who responded with
only moderate (9.7±2.4%) hypertrophy were those where the
number of myonuclei per muscle fibre did not increase and the
myonuclear domain size remained below 2,000 μm2 54. This
value was proposed as a ‘ceiling’ of the myonuclear domain
size beyond which additional hypertrophy can only be realised
by addition of new myonuclei54. The proposed values of a hy-
pertrophy threshold or a ceiling of the myonuclear domain size
are somewhat arbitrary. In this perspective it is interesting to
note that recently for a variety of species it has been shown that
myonuclear domain size scales in proportion to body mass61.
Thus, a myonuclear domain size ceiling or hypertrophy thresh-
old may vary between species.
There is, however, a lack of knowledge regarding the time
course of changes in the number of myonuclei during hyper-
trophy62. In one such study significant hypertrophy of the plan-
taris muscle was attained after 2 weeks of overload without a
concomitant increase in myonuclear number33. Consequently,
the myonuclear domain size increased and only after 4 weeks
of overload did the number of myonuclei increase33. This ob-
servation corresponds with the notion of a ceiling of hypertro-
phy where further hypertrophy after 2 weeks of overload
requires the addition of new myonuclei. A recent study casts
some doubt on this conclusion as they found a stunning dou-
bling in muscle size after only two weeks of overload in satel-
lite cell depleted mice63. Although one could argue that the
muscle fibres would be of lower functional capacity the authors
reported normal single muscle fibre function. Apparently the
myonuclei do have a reserve capacity. The acquisition of new
myonuclei does take time and requires proliferation of satellite
cells, that can be detected as early as 1 week after induction of
overload58, and subsequent differentiation into a myonucleus.
This may only result in a significant increase in the number of
myonuclei after more than 2 weeks of overload33, emphasising
the need for a reserve capacity of the myonuclei to cope with
sudden changes in demand for mRNA transcripts. It is thus pos-
sible that doubling in muscle size within two weeks in satellite
Reference Species Age Model Duration N Muscle change change change 
(days, months) MN (%) FCSA (%) MD (%)
29 R-SD♀ 180 g Overload 10 weeks 3 PL 61-109 36-90 =
33 R-W♂ 5 mo Overload 28 days 5 PL ↑ 33 =
25 mo 3 ↑ 33 =
51 R-SD♀ 212 g Overload 90 days 6 PL 44 46 =
Overload+IR 6 = = =
56 R-W♂ 152 g Overload 28 days 6 EDL ND 21 (ww) =
Overload+IR 6 -24 (ww) 19
57 R-W♂ 4-5 mo Overload 28 days 8 EDL ND 18 (ww) =
(450-500 g) Overload IR 8 = (ww) =
54 H♀ 28 RT 16 weeks 13 VL = 27 17
63 13 = 17 16
54 H♂ 26 RT 16 weeks 13 VL 19 27 10
65 13 = 17 10
59 H♂ 24 RT 90 days 15 VL = 17 17* 
H: Human; R: Rat; ♀: Female; ♂: Male; W: rat strain Wistar; SD: rat strain Sprague-Dawley; Age in years for human and in mo (months) for rats; (N):
number of participants / animals; MN: myonuclear number; FCSA: fibre cross-sectional area; MD: myonuclear domain; ww: % change in wet weight;
Muscles: VL: vastus lateralis; PL: Plantaris; EDL: Extensor digitorum longus; IR: irradiation; All changes have been expressed as change in hypertrophied
compared to control muscles; =: no significant change with hypertrophy; *:change estimated from authors graph.
Table 1. Studies investigating the effect of hypertrophy on the myonuclear domain size.
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Reference Species Age Model Duration N Muscle change change change 
(months) (days, months) MN (%) FCSA (%) MD (%) 
Bed rest 
101 H, ♂ 31 yrs B 2 mo 6 VL = = = 
4 mo 6 = -35 -35* 
Denervation
74 R-SD, ♂ adult DNV 14 d 5 Diaph, I = +15 +26
Diaph, IIA = = =
Diaph, IIX = -46 -51
Diaph, IIB -67 -69
75 M1 4 DNV 10 d - PL = -43* -43*
4 mo = -58* -54*
11 R-W, ♂ 1.5 DNV 2.5 mo EDL -172 -95 -
102 R-W, ♀ 170-200 g DNV 7 d -7 fibres SM = - -37
14 d = - -60
103 M-NMRI, ♀ - DNV 7 d - EDL = = -
14 d = -29*
21 d = -51
14 d SOL = -42*
21 d = -55 
104 R-WI/Hick, ♂ 4 DNV 20 mo 3 EDL -36 -86* -88
4 mo 3 -53 -97* -96
7 mo 3 -68 -98* -92
11 R-W, ♂ 1.5 DNV 2.5mo SOL -60 -99 -
14 R-W, ♂ 5 DNV 7 d 5 Gast = -47 - ca 45 
Spinal cord injury 
71 R-SD, ♀ adult SI 4 d 5 SOL, I = -41 -36
2 mo 5 -25 -66 -55 
68 R-SD, ♀ adult SI 10 d 4-5 SOL -25 - - 
53 C, ♀ adult SI 6 mo 3 SOL, I = -66 -64
SOL, II -32 -74 -60 
Hindlimb suspension 
97 R-F344.BN, ♂ 6 HLS 7 d 6 SOL = -24 =
14 d 6 -36* -62 -41* 
52 R-W, ♂ 3 HLS 14 d 8 SOL -31 -50 -28 
73 R-W, ♀ 3 HLS 14 d 4 SOL, I +20 -55 -63
SOL, II +15 -44 -44
PL, I = = =
PL, II = -29 -40
105 R, F344.BN, ♂ 6 HLS 14 d 6 SOL -37* -72 -42* 
72 R-SD, ♀ 3 HLS 14 d 4 SOL -17 -55 -45 
106 M-C57BL/6J,♂ 2 HLS 14 d ? SOL = -40ww -
28 d = =
42 d = =
56 d = =
Space flight
70 H, ♀, ♂ - S 11 d 5 VL,I = = =
VL,II -18 -47 -23 
107 R-F344, ♂ adult S 10 d 10 SOL, I = -23 =
SOL, II = -12 =
76 R-SD, ♂ adult S 14 d 5 SOL, I -14* -46* -31*
SOL, II = = = 
Tenotomy
103 M-NMRI,♀ - T 14 d - EDL = -18 - 
H: Human; R: Rat; M: Mouse; C: Cat; ♀: Female; ♂: Male; SD: rat strain Sprague-Dawley; W: rat strain Wistar; WI/HICK: rat strain WI/HICK;
F344: rat strain Fischer 344; F344.BN: rat strain Fischer344 x Brown Norway; B: Bed rest; DNV: denervation; SI: spinal cord injury; HLS: Hind-limb
suspension; S: Space flight; T: Tenotomy; (N): number of animals; MN: myonuclear number; FCSA: fibre cross-sectional area; MD: myonuclear domain;
Muscles: Diaph, Diaphragm; PL, Plantaris; EDL, Extensor digitorum longus; SM, Sternocleidomastoideus; SOL, Soleus; TA, Tibialis anterior; Gast,
gastrocnemius; I, II(A,B) refer to muscle fibre type; All changes have been expressed as the change compared to a control normal muscles; =: no significant
change between young and old animals; -: not reported; *: change estimated from authors graph; ww: % change in wet weight muscle mass.
Table 2. Studies investigating the effect of atrophy on the myonuclear domain size.
S.F.T. Van der Meer et al.: Is the myonuclear domain size fixed?
292
cell depleted mice is realised by nuclei that are ‘working flat
out’. This may cause, admittedly speculative, nuclear dysfunc-
tion that over time may jeopardize the maintenance of the mus-
cle fibres by attenuated protein turnover. It would therefore be
interesting to know to what extent the quality of the muscle fi-
bres of these hypertrophied muscles is affected over the life
span of the animal. The addition of new myonuclei is a costly
process and the fact that hypertrophy in normal organisms is
associated with nuclear accretion is an indication of the impor-
tance of acquisition of new myonuclei for the maintenance of
the increased muscle mass.
Overall, it appears that the nuclear domain is far from fixed,
but rather increases during the development of hypertrophy
(scenario in Figure 4C). However, there might be a ‘ceiling’
of the myonuclear domain size, or a maximal volume of cyto-
plasm that can be controlled by a single nucleus, beyond which
hypertrophy can only proceed and be maintained for a pro-
longed time by addition of new myonuclei.
Myonuclear domain and decreases in muscle size
Skeletal muscle atrophy is largely, if not solely, attributable
to a decrease in fibre size. According to the concept of the my-
onuclear domain this should be associated with a proportional
decrease in the number of myonuclei to maintain the myonu-
clear domain size. Below we will discuss what happens during
muscle atrophy resulting from disuse and ageing, while ignor-
ing the loss of fibres contributing to the atrophy during ageing
(a nonexistent fibre will have no myonuclei).
Myonuclei can be eliminated by a process called apoptosis.
Originally, this term was given to the types of cell deaths that
were executed by intrinsic ‘suicide’ instructions and charac-
terised by cell shrinkage and fragmentation of cell organelles
that are ultimately digested by rapid phagocytosis64,65. During
apoptosis, a cell nucleus can be degraded without the imme-
diate destruction of the cell. In skeletal muscle, the ultimate
event of nuclear apoptosis is the fragmentation of myonuclear
DNA executed by so-called caspases. The activity of these en-
zymes is regulated by complex signalling pathways that in-
volve the interaction of different pro- and anti-apoptotic
factors66. Unlike other cell types, nuclear apoptosis in muscle
fibres is very rare under normal physiological conditions67,68,
but there is an increased expression of pro-apoptotic factors
and number of apoptotic myonuclei following various atrophic
stimuli66,69. The significance of nuclear apoptosis during at-
rophic conditions is, however, controversial. 
Atrophy
The concept of a constant myonuclear domain size implies
that muscle fibres loose myonuclei in proportion to (disuse-
induced) atrophy. However, several observations do cast doubt
on this concept in case of muscle atrophy. After 11 days of
space flight, for instance, type II fibres in the vastus lateralis
muscles from 2 out of 5 astronauts lost 18% of the myonuclei
per mm fibre length, while the fibres atrophied by 47%70. This
thus would result in a decreased, rather than constant, myonu-
clear domain size. Animal studies on the effect of disuse on
the myonuclear number have generated some equivocal results
(overview given in Table 2). In some studies a 50-70% reduc-
tion of the FCSA was accompanied with a considerable de-
crease in the number of myonuclei52,71,72, whereas in other
studies a similar magnitude of atrophy was not associated with
any change in the myonuclear number14,73-75. Part of this dis-
crepancy might be explicable by the different response of type
I and type II fibres to disuse. In rat soleus muscle for instance,
both myonuclear number and FCSA were reduced after 12-
days spaceflight in type I but not in type II fibres76. This is not
unequivocal, however, as in denervated gastrocnemius mus-
cles type I, IIA and IIB fibres all atrophied to the same extent
and at the same rate without loss of myonuclei14. Even in the
studies that observed myonuclear loss, this was not propor-
tional to the magnitude of atrophy, and hence myonuclear do-
main size decreases during atrophy (Table 2), even
independent of fibre type14. The decrease in myonuclear do-
main size is not explicable by a decrease in fibre oxidative ca-
pacity as observed during e.g. denervation77 which would have
to be associated with an increased rather than decreased my-
onuclear domain size.
The maintenance of myonuclei may be an appropriate strat-
egy as the breakdown of myonuclei is an energy requiring
process. Maybe even more important is that the muscle is
‘ready’ to respond to stimuli that induce hypertrophy. Newly ac-
quired myonuclei during hypertrophy in mice muscle are not
lost after subsequent 3 months of denervation78 and this might
provide the muscle with a ‘memory’ for later re-growth. These
and other observations, such as satellite cell proliferation14,79-81,
increased RNA and ribosomal concentration14,82 and higher cap-
illary density77, during the early stages of (denervation-induced)
atrophy suggest that while proteins may be broken down rapidly
the machinery and structures required to rapidly regain muscle
mass are at least to some extent preserved. This machinery may
also be required in the initial stages of atrophy to cope with the
dramatic changes in gene expression83, and synthesis of enzymes
and proteins involved in protein breakdown. This has indeed
been observed after denervation where the expression of atro-
gens is transiently elevated 3-7 days after denervation84-86 coin-
ciding with the period of most dramatic atrophy14,77. During
long-term atrophy, such as induced by denervation, the muscle
regenerative capacity will ultimately be negatively affected87.
These observations highlight a ‘window of opportunity’ where
interventions to maintain muscle mass during hospitalisation
and spaceflight are most effective early after the onset of disuse
atrophy and may lose some of the effectiveness over time.
Ageing
The primary determinant of the age-related muscle weakening
is the loss of muscle mass, also referred to as ‘sarcopaenia’ (see
for review88). The process of sarcopaenia starts to manifest itself
at the age of 60 and is the consequence of both a loss of muscle
fibres and fibre atrophy89. If the concept of a constant myonuclear
domain size would also apply to the ageing muscle, the age-re-
lated atrophy would be associated with a proportional reduction
S.F.T. Van der Meer et al.: Is the myonuclear domain size fixed?
293
of the myonuclear number. Studies that have assessed the effect
of ageing on the number of myonuclei are somewhat contradic-
tory (see for an overview Table 3). The only two reports of a de-
crease in the number of myonuclei per unit muscle fibre length
in old compared to young muscles were in mice28,90, while in
human, rat and bird skeletal muscles, the number of myonuclei
remained unchanged or even increased during ageing. It is not
clear what causes these discrepancies, but the two studies that
reported an age-related decrease in myonuclear number28,90
analysed isolated single fibres, whereas in all other studies my-
onuclear number was determined from muscle cross-sections.
However, even studies using the ‘cross-sectional’ approach have
come to contradictory results with both an increase13,14,33,91-93 and
no change13,41,54,94-97 in myonuclear number during ageing having
been reported. These discrepancies may be more apparent than
real and when one considers also the changes in fibre size most
of the discrepancies are readily explicable. For instance, in the
four studies that did not observe any change in the number of
myonuclei per muscle fibre during ageing there was also no or
only a small change in the FCSA. Only in old women, a sub-
group in the study by Petrella and colleagues54, there was atrophy
without a significant reduction in myonuclear number. In rat gas-
trocnemius muscle there may have been a loss of fibres between
the age of 5 and 25 months which was compensated by an in-
crease in size of the remaining fibres14. This increase in fibre size
is accompanied with a proportional increase in the number of
myonuclei, thus maintaining the myonuclear domain size14, also
in the plantaris muscle33. It thus seems that despite loss of muscle
fibres during ageing, the relationship between fibre size and my-
onuclear number is maintained.
Another factor to consider is the absence of age-related
muscle atrophy in some studies suggesting that ageing had not
yet manifested in the muscles from the ‘old’ participants. In
fact, several studies indicate that the age-related reduction in
muscle volume and/or function occur mainly after the age of
70 (see for review88) and the mean age of the ‘old’ participants
recruited in several studies41,54,94,95 was below the age of 70
years. Similarly, in two96,97 out of the three studies that reported
Reference Species Age Age Muscle change change change
young (N) old (N) MN (%) FCSA (%) MD (%) 
Increase in MN
91 H, ♀ 23±3 y (14) 76±4 y (14) VL 19 - - 
H, ♂ 26±3 y (15) 74±4 y (13) VL 19 - - 
92 H, ♂ 20±1 y (8) 76±1 y (8) VL, II 13 -27 -31 
93 R-WI/Hick 4 mo. (-) 32 mo. LA 39 -54 -80
13 R-F344 5 mo. (6) 24 mo. (8) SOL, I 33 = -24
SOL, IIA 65 = -34
14 R-W 5 mo. (15) 25 mo. (10) Gast 36 37 =
99 H, ♂ 27±2 (5) 82±3 (9) VL, I 23 23 =
H, ♀ 28±2 (4) 84±8 (8) VL, I 38 38 =
VL, IIA 44* -15 -41
No change in MN
99 H, ♂ 27±2 (5) 82±3 (9) VL, IIA = -31 -33 
41 H, ♀♂ 22 (6) & 46 y (6) 65.1 y (6) Mixed = = - 
94 H, ♀♂ 24±4 y (4) 69±7 y (7) Unknown = = - 
54 H, ♀ 27.9±1.1 y (13) 62.8±1.0 y (13) VL = -18 = 
H, ♀ 26.1±1.4 y (13) 64.5±1.1 y (13) VL = = = 
95 H, ♂ 22.5±5.8 y (7) 65.0±6.0 y (8) VL = -24 = 
96 R-BN, ♂ 5.5 mo (5) 27 mo (5) TA = -8 
97 R-F344.BN, ♂ 6 mo (6) 32 mo (6) SOL = -27 -29 
13 R-F344 5 mo (6) 24 mo (8) PL = = =
I,IIA, IIB/D
33 R-W 5 mo (12) 25 mo (10) PL = = =
Decrease in MN
28 M 12 mo (-) 26-29 mo TA -20* -33 =
90 M, ♀ 14 mo (-) 23 mo EDL -20 ↓ = 
SOL -16 ↓ = 
H: Human; R: Rat; ♀: Female; ♂: Male; (N): number of participants / animals; RT: Resistance training; MN: myonuclear number; FCSA:
fibre cross-sectional area; MD: myonuclear domain; Muscles: VL: vastus lateralis; PL: Plantaris; EDL: Extensor digitorum longus. All changes
have been expressed as change in old compared to young muscles; =: no significant change between young and old animals; *:change estimated
from authors graph.
Table 3. Studies on the impact of ageing on the myonuclear domain size.
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no change in the number of myonuclei per muscle fibre for the
aged rat muscle, the age of the ‘old’ rats was still 4-5 months
below the mean life expectancy of their strain and not really
old animals98. 
At very old age (i.e. >70% of the maximal live expectancy)
the nuclear domain size may decrease, something that has in-
deed been observed in muscles from very old (32-month-old)
rats93. Although in humans an increased number of myonuclei
per fibre have been observed at advanced age91, this did not
necessarily result in a decreased myonuclear domain size99.
What is interesting, however, is that the distribution of myonu-
clei that is thought to be such that it minimizes diffusion dis-
tances between nuclei27, becomes more heterogeneous during
ageing90,99 and may impair local protein turnover.
Overall, the pattern emerges that up to a certain age the
number of myonuclei per muscle fibre are not substantially af-
fected by ageing even when muscle fibre atrophy has started.
Further it seems that during ageing the number of myonuclei
per muscle fibre may even increase. For humans, this may be
after 70 years of age, while in rats this age may (somewhat)
depend on the strain. As a result of the atrophy and increase in
myonuclear number, myonuclear domain size may decrease at
advanced age.
Concluding remarks
The short answer to the question addressed in this review is
that the myonuclear domain size is not fixed. Although one
might then suggest abandoning the concept of a constant my-
onuclear domain entirely, this is too radical as in the normal sit-
uation a relationship between fibre size and myonuclear
number does exit. It is only during maturational growth, ageing
and when the muscle adapts to altered functional demands that
deviations occur. Deviations might be understood when one re-
alises that: 1) addition and removal of myonuclei is an expen-
sive process and 2) a nucleus needs a reserve capacity to be
able to respond to sudden changes in transcriptional demands
and 3) during hypertrophy it must be able to bridge the period
between activation and incorporation of satellite cells into the
myofibre. The preservation of myonuclei during atrophy may
be an excellent strategy to save energy and at the same time
have the muscle ‘ready’ for subsequent recovery of muscle
mass. Another factor that might be of importance, as we sug-
gested before100, is the distribution of myonuclei within the
muscle fibre. While a lot of attention has been given to the size
of the myonuclear domain in terms of cytoplasmic volume,
more attention may need to be given to the number per fibre
perimeter and distribution of the myonuclei over the perimeter
of the fibre, given that during for instance maturational growth
the number of myonuclei per fibre radius remains constant41.
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